Research Funding

  • May 4, 2015 - April 30, 2021 - Improving risk allocation and developing novel therapies for children with T-ALL , Co-Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01CA193776
  • June 1, 2010 - May 31, 2015 - Interplay of Innate and Adaptive Immunity in Lupus Pathogenesis , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01AI089831
  • July 11, 2003 - June 30, 2007 - Role of CD45 in Hematopoiesis and Lymphomagenesis , Principal Investigator . Sponsor: NIH, Sponsor Award ID: K08CA098418

Education

University of Iowa, B.S August, 1988, Physiology
Washington University School of Medicine, Ph.D., May, 1997, Developmental Biology
Washington University School of Medicine, M.D., May, 1997, Medicine
University of California, San Francisco, Resident, 1997-99, Pediatrics
University of California, San Francisco, Fellow, 1999-03, Hematology/Oncology
University of California, San Francisco, Post-Doctoral Fellow, 2001-2007, Immunology

Honors & Awards

  • 1987
    Mortar Board Honor Society, University of Iowa
  • 1988
    Honors Graduate, University of Iowa
  • 1988
    University of Iowa Homecoming Award for Excellence in Scholarship, Leadership, and Service
  • 1990
    Medical Scientist Training Program Fellowship, Washington University
  • 1990
    Edmond V. Cowdry Prize in Histology, Washington University
  • 1993
    Spencer T. and Ann W. Olin Foundation Medical Scientist Fellowship, Washington University
  • 1995
    Barbara Jackshik Award for Excellence in the Field of Cellular Regulation, Washington University
  • 1996
    American College of Physicians Award for Excellence in Physical Diagnosis
  • 1997
    American Medical Women's Association Janet M. Glasgow Memorial Achievement Citation, presented to women graduating in the top ten percent of their medical school class
  • 1997
    Missouri State Medical Association Award for Outstanding Achievement in Medicine
  • 1997
    Alpha Omega Alpha, Washington University School of Medicine
  • 1997
    UCSF Molecular Medicine Research Fellowship Program
  • 2001
    Molecular Oncology Investigator, University of California San Francisco Cancer Center
  • 2004
    FASEB Summer Protein Phosphatase Research Conference Poster Award
  • 2005
    Nominee, Department of Pediatrics Housestaff Teaching Award, UCSF
  • 2007-10
    Nominee, Fellow Mentoring Award, Department of Pediatrics, UCSF
  • 2008
    St. Baldrick's Foundation, Young Investigator Career Development Award
  • 2009
    Alex Lemonade Stand Young Investigator Career Development Award
  • 2010
    Histiocyte Society Nezelof Prize in Basic Science

Selected Publications

  1. Lust H, Schultz LM, Kwon S, Roloff GW, Aldoss I, Baggott C, John S, Rossoff JE, McNerney KO, Fabrizio VA, Talano JA, Moskop A, Curran KJ, Phillips CL, Karras N, Baumeister SHC, Cooper SL, Hermiston M, Satwani P, Qayed M, Raikar SS, MacMillan M, Hall E, Nguyen K, Cassaday RD, Kopmar NE, Kota VK, Mathews J, Shaughnessy P, Schwartz MS, Ladha A, Yaghmour G, Kumaran MV, Bachanova V, Tracy S, Othman T, Luskin MR, Chen EC, Advani AS, Jeyakumar N, Miller K, Zhang A, Sutherland KC, Shah BD, Muffly L, Faramand R Real-world outcomes for young adult patients receiving CD19 CAR T-cell therapy.  View on PubMed
  2. Moss WJ, Hermiston M, Warnakulasuriya S Betel nut sweets present growing health threat to children.  View on PubMed
  3. Naymagon L, Roehrs P, Hermiston M, Connelly J, Bednarski J, Boelens JJ, Chandrakasan S, Dávila Saldaña B, Henry MM, Satwani P, Ray A, Walkovich K, Teachey D, Behrens EM, Canna SW, Kumar A Perspectives on the current diagnostic and treatment paradigms in secondary hemophagocytic lymphohistiocytosis (HLH).  View on PubMed
  4. Henderson LA, Abraham RS, Ahmed A, Blount L, Canna SW, Chaimowitz NS, Chandrakasan S, Coates B, Connelly JA, Cooper MA, Duncan CN, French A, Hazen M, Hermiston ML, Nolan B, Ray A, Rose MJ, Satter LF, Schulert G, Tejtel SKS, Vogel T, Walkovich K, Zinter MS, Behrens EM Multidisciplinary approach to treating complex immune dysregulation disorders: an adaptive model for institutional implementation.  View on PubMed
  5. Dao ATT, To NT, Nguyen CH, Truong KD, Tran TD, Yen SS, Pheng ALH, Hermiston M, Nguyen PD The outcomes of pediatric extracranial malignant germ cell tumors: A decade of experience from a single institution in Southern Vietnam.  View on PubMed
  6. Shah NN, Schafer ES, Chi YY, Malvar J, Heym KM, Place AE, Burns M, Chang BH, Slone T, Verma A, Gossai N, Shaw PH, Burke MJ, Hermiston M, Schore RJ, Cooper T, Pauly M, Rushing T, Jarosinski P, Florendo E, Yates B, Widemann BC, Peer CJ, Figg WD, Silverman LB, Bhojwani D, Wayne AS. Vincristine Sulfate Liposome Injection with Combination Chemotherapy for Children, Adolescents, and Young Adults with Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium Trial. Pediatr Blood Cancer. 2025 Feb 12; e31584.  View on PubMed
  7. Allyson Flower, Troy C. Quigg, David T. Teachey, Megan Lim, Yanling Liao, Lauren Harrison, Erin Morris, Amir Steinberg, Stephan Voss, Rodney R Miles, Xiaokui Mo, Joseph Stanek, Adam Olshen, Michelle Hermiston, Alix E. Seif, Mitchell S. Cairo. A Phase 1 Trial of Targeted Immunotherapy with Daratumumab Following Myeloablative Total Body Irradiation (TBI)-Based Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) in Children, Adolescents and Young Adults with High-Risk T-Cell Acute Lymphoblastic Leukemia and Lymphoma (T-ALL/T-LLy) (ALLO-T-DART): A Ptctc Facilitated Study. Transplantation and Cellular Therapy. 2025 Feb 1; 31(2):s433-s434.  View on PubMed
  8. Christopher C. Dvorak, William C. Temple, Gabriel Salinas Cisneros, Julia Chu, Lena E. Winestone, Christine S. Higham, Kristin A. Shimano, Sandhya Kharbanda, Serine Avagyan, Michelle Hermiston, James N. Huang, Janel Renee Long-Boyle. Fludarabine Pharmacokinetic-Model-Based Dosing Minimizes the Risk of Graft Rejection in Pediatric Patients Undergoing Mismatched Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 2025 Feb 1; 31(2):s173-s174.  View on PubMed
  9. Gabriel Salinas Cisneros, Janel Renee Long-Boyle, William C. Temple, Julia Chu, Serine Avagyan, Lena E. Winestone, Christine S. Higham, Kristin A. Shimano, James N. Huang, Michelle Hermiston, Sandhya Kharbanda, Christopher C. Dvorak. High Exposure of Intravenous Alemtuzumab Is Associated with Increased Risk of Double-Stranded DNA Viral Infections in Patients with Non-Malignant Disease Undergoing Allogeneic HCT. Transplantation and Cellular Therapy. 2025 Feb 1; 31(2):s186.  View on PubMed
  10. Lauren Appell, Arunkumar Modi, Christina Baggott, Khanh Nguyen, Snehit Prabhu, Holly L Pacenta, Vanessa A. Fabrizio, Christine L. Phillips, Jenna Rossoff, Heather Emily Stefanski, Julie A Talano, Amy Moskop, Rachel Phelan, Susanne Baumeister, Michael R. Verneris, Erin M. Hall, Gary Myers, Nicole Karras, Stacy Cooper, Muna Qayed, Sunil S. Raikar, Lena E. Winestone, Michelle Hermiston, Prakash Satwani, Christa Krupski, Amy K. Keating, Danielle Friedman, Kevin J. Curran, Crystal L. Mackall, Samuel John, Theodore W Laetsch, Kevin Owen McNerney, Liora Schultz. Liberalizing Requirements for Hospital Proximity Post-CD19 CAR for Children with Low Burden B-ALL at Infusion. Transplantation and Cellular Therapy. 2025 Feb 1; 31(2):s230-s231.  View on PubMed
  11. Christopher C. Dvorak, William C. Temple, Gabriel Salinas Cisneros, Julia Chu, Lena E. Winestone, Christine S. Higham, Kristin A. Shimano, Sandhya Kharbanda, Serine Avagyan, Michelle Hermiston, James N. Huang, Janel Renee Long-Boyle. Younger Children Have Increased Mixed Myeloid Chimerism with Busulfan-Based Conditioning for Hematopoietic Cell Transplantation of Non-Malignant Disease. Transplantation and Cellular Therapy. 2025 Feb 1; 31(2):s179-s180.  View on PubMed
  12. Marinoff AE, Thrall A, Aaronson K, Braun BS, Castellanos M, Chu J, Hermiston M, Huang BJ, Levinson A, Southworth E, Winger BA, Olshen A, Stieglitz E. Thrombopoietin Receptor Agonists for Thrombocytopenia in Pediatric Hematologic Malignancies. Pediatr Blood Cancer. 2025 Mar; 72(3):e31528.  View on PubMed
  13. Chandrakasan S, Allen CE, Bhatla D, Carter J, Chien M, Cooper R, Draper L, Eckstein OS, Hanna R, Hays JA, Hermiston ML, Hinson AP, Hobday PM, Isakoff MS, Jordan MB, Leiding JW, Modica R, Nakano TA, Oladapo A, Patel SA, Pednekar P, Riskalla M, Sarangi SN, Satwani P, Tandra A, Walkovich KJ, Yee JD, Zoref-Lorenz A, Behrens EM, REAL-HLH investigators. Emapalumab Treatment in Patients With Rheumatologic Disease-Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review Study. Arthritis Rheumatol. 2025 Feb; 77(2):226-238.  View on PubMed
  14. Carol Fries Simpson, Lik Wee Lee, Hongyue Wang, Diana G. Adlowitz, Philip Rock, Brent L. Wood, Rachel E. Rau, Kara L. Davis, Anne Angiolillo, Meenakshi Devidas, David T. Teachey, Karen R Rabin, Birte Wistinghausen, Donald Barkauskas, Robert J. Hayashi, Richard Burack, Carl E Allen, Michelle L. Hermiston, Ilan R. Kirsch. Immunoglobulin Sequencing Biologically Distinguishes B-Lymphoblastic Lymphoma from Acute Lymphoblastic Leukemia and Reveals a Spectrum of Disease Dissemination across Clinical Stages. Blood. 2024 Nov 5; 144(Supplement 1):2838.  View on PubMed
  15. Melinda G Pauly, Yueh-Yun Chi, Jemily Malvar, Roy Leong, Susan Colace, Nathan Gossai, Nobuko Hijiya, Chintan Parekh, Susan R Rheingold, Anupam Verma, Bill H Chang, Todd M Cooper, Andrew Doan, Yamilet Huerta, Kelly Elizabeth Faulk, Diane Hanna, Kenneth Matthew Heym, Mallorie M. Heneghan, Joel Kaplan, Luciano Dalla-Pozza, Seth E. Karol, Andrew E. Place, Jenna Rossoff, Eric S. Schafer, Tamra Slone, Michelle L. Hermiston, Maria Luisa Sulis. Retrospective Cohort Analysis of Response and Survival of Children, Adolescents, and Young Adults (CAYA) with Relapsed and/or Refractory (R/R) T-Cell Acute Lymphoblastic Leukemia (T-ALL) and Lymphoma (T-LL) Treated with Curative Intent: A TACL Consortium Study. Blood. 2024 Nov 5; 144(Supplement 1):4187.  View on PubMed
  16. Etan Orgel, Sarah K. Tasian, Yueh-Yun Chi, Jemily Malvar, Christina M. Dieli-Conwright, Rubi Buxton, Mackenzie Frederick, Hannah Williams, Karen R Rabin, Susan R Rheingold, Robin Norris, Tamara P. Miller, Brent L. Wood, Ellynore Florendo, Ellen Chang, Lisa Hartman, Mallorie M. Heneghan, Michelle L. Hermiston, Joel Kaplan, Tamra Slone, Deepa Bhojwani, Alan S. Wayne, Steven D. Mittelman. Trial in Progress: Update on the TACL T2020-003 Randomized Phase 2 Trial to Improve Diet and Exercise in Acute Lymphoblastic Leukemia (IDEAL-2). Blood. 2024 Nov 5; 144(Supplement 1):2828.1-2828.1.  View on PubMed
  17. Melissa Hines, E. Trentham, K. Ryan, C. Price, B. Ehrlich, M. Hermiston, A. Asya Agulnik. PP114 Topic: AS13–Hematology/Oncology/Stem Cell Transplant/Immunology: MORTALITY IN CHILDREN WITH HEMOPHAGOCYTIC LYMPHOHISTIOCTYOSIS IN LOW-, LOW-MIDDLE-AND UPPER MIDDLE-INCOME COUNTRIES: A SYSTEMATIC REVIEW AND META-ANALYSIS. Pediatric Critical Care Medicine. 2024 Nov 4; 25(11S):e50-e50.  View on PubMed
  18. Higham CS, Shimano KA, Kharbanda S, Chu J, Cisneros GS, Winestone LE, Dara J, Huang JN, Hermiston ML, Long-Boyle JR, Dvorak CC. Cyclophosphamide and Thiotepa Increases Risk of Transplant-Associated Thrombotic Microangiopathy. Transplant Cell Ther. 2024 Sep; 30(9):931.e1-931.e10.  View on PubMed
  19. Hayashi RJ, Hermiston ML, Wood BL, Teachey DT, Devidas M, Chen Z, Annett RD, Asselin BL, August K, Cho S, Dunsmore KP, Freedman JL, Galardy PJ, Harker-Murray P, Horton TM, Jaju A, Lam A, Messinger YH, Miles RR, Okada M, Patel S, Schafer ES, Schechter T, Shimano KA, Singh N, Steele A, Sulis ML, Vargas SL, Winter SS, Wood C, Zweidler-McKay PA, Loh ML, Hunger SP, Raetz EA, Bollard CM, Allen CE. MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231. Blood. 2024 05 16; 143(20):2053-2058.  View on PubMed
  20. Chandrakasan S, Jordan MB, Baker A, Behrens EM, Bhatla D, Chien M, Eckstein OS, Henry MM, Hermiston ML, Hinson AP, Leiding JW, Oladapo A, Patel SA, Pednekar P, Ray AK, Dávila Saldaña B, Sarangi SN, Walkovich KJ, Yee JD, Zoref-Lorenz A, Allen CE. Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab. Blood Adv. 2024 05 14; 8(9):2248-2258.  View on PubMed

Go to UCSF Profiles, powered by CTSI